Início › Mieloma Múltiplo › Nebraska
Ensaios clínicos de Mieloma Múltiplo em Nebraska
18 estudos para Mieloma Múltiplo estão buscando participantes em locais em Nebraska.
Cidades em Nebraska
Texto oficial do estudo (Inglês)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05552222A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- NHO Revive Research Institute, LLC, Lincoln
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05623020A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Nebraska Cancer Specialists, Omaha
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07518186TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Nebraska Medical Center, Omaha
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT02693535Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
- Nebraska Cancer Institute, Omaha
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04879043MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Bryan Medical Center, Lincoln
- NHO Revive Research Institute, LLC, Lincoln
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT06152575Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- University of Nebraska Medical Center, Omaha
Recrutando
Idades 19 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT04898790Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT04566328A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
- University of Nebraska, Omaha
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT07280013A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- University of Nebraska Medical Center, Omaha
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT07284758Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
- Unversity of Nebraska Medical Center, Omaha
Recrutando
Idades 19 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05135351A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
- University Of Nebraska Medical Center, Omaha
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06121843A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- NHO Revive Research Institute, LLC /ID# 267869, Lincoln
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT05650632Halt Aging in Survivors of Blood Cancers
- University of Nebraska Medical Center, Omaha
Recrutando
Idades 50 e acima · Todos os sexos · Atualizado em 1 de jul. de 2026 · NCT07292272Integrated Cancer Repository for Cancer Research
- Mary Lanning Healthcare, Morrison Cancer Center, Hastings
- Faith Regional Health Services, Carson Cancer Center, Norfolk
- Great Plains Regional Medical Center, North Platte
- e mais 3
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de jun. de 2026 · NCT04068597Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- e mais 2
RecrutandoFase 3
Todas as idades · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT05561387A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
- Nebraska Cancer Specialists, Omaha
RecrutandoFase 2
Todas as idades · Todos os sexos · Atualizado em 16 de jan. de 2025 · NCT06115135Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.